Clinical observation of perioperative continuous infusion of dexmedetomidine on early rehabilitation of patients undergoing open surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16010184

Enrollment

Unknown

Registered

2016-12-18

Start date

2016-12-19

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal disease

Interventions

A group:Intraoperative use of dexmedetomidine

B group:Saline

C group:Postoperative use of dexmedetomidine

D group:Intraoperative and postoperative use of dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. ASA I ~ III; 3. Scheduled to implement laparotomy in West China Hospital of Sichuan University.

Exclusion criteria

Exclusion criteria: 1. atrioventricular block, sinus bradycardia and other serious heart disease; 2. dexmedetomidine or intraoperative other allergies allergy; 3. patients have long-term use of analgesics, antidepressant history; 4. patients with mental disorders can not match; 5. patients refused; 6. Other investigational drugs were administered within 3 months of enrollment or other clinical trials; 7. Pregnant women and lactating women.

Design outcomes

Primary

Measure	Time frame
early rehabilitation;	—

Countries

China

Contacts

Public ContactBin Liu

West China Hospital, Sichuan University

liubinhxyy@163.com+86 18980601540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026